Pharma Companies Say New Drug Price Law Leaves Them in Limbo

Drugmakers say a new US law aimed at cutting prices on top-selling medicines after they’ve been on the market for several years has them stuck in limbo.
Read More

What's Hot

Teenage Cancer Trust appoints Professor Rachael Hough to Board of Trustees

Update on Long COVID; Social Stress on the Immune System

Top medical schools reject rankings as measure of success, quality

Pharma Companies Say New Drug Price Law Leaves Them in Limbo

Teenage Cancer Trust appoints Professor Rachael Hough to Board of Trustees

Update on Long COVID; Social Stress on the Immune System

Top medical schools reject rankings as measure of success, quality

Eisai: Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer’s Disease Accepted by European Medicines Agency

Teenage Cancer Trust appoints Professor Rachael Hough to Board of Trustees

Update on Long COVID; Social Stress on the Immune System

Top medical schools reject rankings as measure of success, quality

Eisai: Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer’s Disease Accepted by European Medicines Agency

What to Expect from China’s Travel Rebound

COVID-19 Test Centres Empty In Abuja

FDA advisers raise doubts about moving to yearly Covid boosters

Review of billions of COVID-19 wage benefits not worth the effort, CRA head says

Westside Wellness Opens New Spa for IV Hydration Vitamin Therapy in Santa Monica

Researchers solve an 80-year-old medical mystery that caused baby deaths

What's Hot

Pharma Companies Say New Drug Price Law Leaves Them in Limbo

Related Posts